Arthritis Care & Research· 2012Q1· Review

2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

Jasvinder A. Singh, Daniel E. Fürst, Aseem Bharat, Jeffrey R. Curtis et al.

1,803citations
Q1SCImago
2012year

Short summary

Updated guidelines provide recommendations for using conventional synthetic, targeted synthetic, and biologic disease-modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis (RA) treatment.

AI-generated from the title and abstract; the full text is not read.

TakeawaysIn the app

Key pointsIn the app

Ask the paperIn the app

The rest is in the Pofolia app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

Get it on Google Play Download on the App Store

Field: Rheumatology

RheumatologyMedicine